THE USE OF GENETICALLY-MODIFIED TUMOR-CELLS AS A VACCINE IN PATIENTS WITH CANCER - THE DEFINITION OF INTERMEDIATE END-POINTS

Authors
RANKIN EM
Citation
Em. Rankin, THE USE OF GENETICALLY-MODIFIED TUMOR-CELLS AS A VACCINE IN PATIENTS WITH CANCER - THE DEFINITION OF INTERMEDIATE END-POINTS, European journal of cancer, 31A, 1995, pp. 23-23
Citations number
1
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
3
Pages
23 - 23
Database
ISI
SICI code
0959-8049(1995)31A:<23:TUOGTA>2.0.ZU;2-7